As of November 6, 2026, Immatics N.V. is a publicly traded company (Nasdaq: IMTX). The largest holder reporting an active stake on Schedule 13D is Perceptive Advisors, at 7.6%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include T. Rowe Price (16.1%), RTW Investments (9.6%), Suvretta Capital Management, LLC (8.3%) (Schedule 13D/A, August 27, 2026).
Is this your company?
About to sign with, pay or invest in Immatics N.V.? See the free Snapshot first.
Free to see. No signup.
Is Immatics N.V. a real, registered company?
- Immatics N.V. files with the SEC under CIK 1809196 (its SEC filings).
- Its shares are listed under the ticker IMTX on Nasdaq (SEC company record).
- Incorporated in P7; business address in Tubingen, 2M, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Immatics N.V. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Perceptive Advisors (filed 2026-08-27).
Who are Immatics N.V.'s owners and officers?
Immatics N.V.: business address in Tubingen, 2M; industry Biological Products, (No Diagnostic Substances) (Schedule 13D/A, 2026-08-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-08-27 | Perceptive Advisors LLC | 7.6% |
| Schedule 13G/A, 2026-08-14 | Baker Bros. Advisors LP | 7% |
| Schedule 13G/A, 2026-05-15 | Rtw Investments, LP | 9.6% |
| Schedule 13G/A, 2026-05-15 | Vestal Point Capital, LP | 4.6% |
| Schedule 13G, 2026-05-15 | The Toronto-Dominion Bank | 5.5% |
| Schedule 13G/A, 2026-05-15 | T. Rowe Price Investment Management, Inc. | 16.1% |
| Schedule 13G/A, 2026-02-17 | Rtw Investments, LP | 8.5% |
| Schedule 13G/A, 2026-02-13 | Suvretta Capital Management, LLC | 8.3% |
| Schedule 13G/A, 2025-11-14 | Baker Bros. Advisors LP | 9.95% |
| Schedule 13G/A, 2025-11-14 | Rtw Investments, LP | 7.3% |
| Schedule 13G/A, 2025-08-14 | T. Rowe Price Investment Management, Inc. | 15.1% |
| Schedule 13G/A, 2025-08-14 | Baker Bros. Advisors LP | 8.4% |
Questions about who owns Immatics N.V.
Who owns Immatics N.V.?
On this page, 6 holders' latest ownership filings report 5% or more of Immatics N.V.: T. Rowe Price Investment Management, Inc. (16.1%, Schedule 13G/A, filed 2026-05-15), Rtw Investments, LP (9.6%, Schedule 13G/A, filed 2026-05-15), Suvretta Capital Management, LLC (8.3%, Schedule 13G/A, filed 2026-02-13), Perceptive Advisors LLC (7.6%, Schedule 13D/A, filed 2026-08-27) and Baker Bros. Advisors LP (7%, Schedule 13G/A, filed 2026-08-14); 1 more is listed above.
Who are the largest shareholders of Immatics N.V.?
By the share each holder's latest filing reports, the largest holders of Immatics N.V. on this page are T. Rowe Price Investment Management, Inc. (16.1%), Rtw Investments, LP (9.6%) and Suvretta Capital Management, LLC (8.3%).
When did T. Rowe Price Investment Management, Inc. buy into Immatics N.V.?
The filings give report dates, not purchase dates. The earliest filing from T. Rowe Price Investment Management, Inc. on this page is the Schedule 13G/A, filed 2025-08-14, reporting 15.1%; its latest, Schedule 13G/A filed 2026-05-15, reports 16.1%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Immatics N.V.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Immatics N.V.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Immatics N.V. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
16 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Immatics N.V. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Perceptive Advisors, a director: 11,246,516 shares (8.4% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-08-27).
- , a director: 11,246,516 shares (8.4% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-08-27).
- Perceptive Life Sciences Master Fund Ltd., a director: 11,246,516 shares (8.4% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2026-08-27).
- , a director: 329,521 shares (0.25% of shares outstanding), held indirectly through By MH-LT-Investments GmbH (Form 3, 2026-03-17).
- , the chief executive and a director: 217,241 shares (0.16% of shares outstanding) (Form 3, 2026-03-18).
Shares outstanding: 134,071,432 as of 2025-12-31, from the company's latest SEC cover page.
How much has Immatics N.V. raised?
No fundraising or offering filing from Immatics N.V. is on file with us.
Keep reading
More on Immatics N.V. and the records around it.
Immatics N.V. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- The Toronto-Dominion Bank also filed stake reports on 5 other companies: eBay Inc. (Aug 2026), Stoke Therapeutics, Inc. (Aug 2026), UroGen Pharma Ltd. (Aug 2026)
- Suvretta Capital Management, LLC also filed stake reports on 22 other companies: Veradermics, Inc (Aug 2026), Abeona Therapeutics Inc. (Aug 2026), Fulcrum Therapeutics, Inc. (Aug 2026)
- Baker Bros. Advisors LP also filed stake reports on 25 other companies: Madrigal Pharmaceuticals, Inc. (Nov 2026), Kodiak Sciences Inc. (Sep 2026), BeOne Medicines Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/immatics-nv